18F-FDG PET/CT Versus Diagnostic Contrast-Enhanced CT for Follow-up of Stage IV Melanoma Patients Treated by Tyrosine Kinase or Immune Checkpoint Inhibitors: Frequency and Management of Discordances Over a 3-Year Period in a University Hospital

Jean-Baptiste Le Goubey; Charline Lasnon; Ines Nakouri; Laure Césaire; Michel Depontville; Catherine Nganoa; Diane Kottler; Nicolas Aide

Preprint

Article

¹⁸F-FDG PET/CT Versus Diagnostic Contrast-Enhanced CT for Follow-up of Stage IV Melanoma Patients Treated by Tyrosine Kinase or Immune Checkpoint Inhibitors: Frequency and Management of Discordances Over a 3-Year Period in a University Hospital

This version is not peer-reviewed.

Jean-Baptiste Le Goubey,

Charline Lasnon,Ines Nakouri,Laure Césaire,Michel Depontville,Catherine Nganoa,Diane Kottler,

Nicolas Aide^*

Jean-Baptiste Le Goubey,

Charline Lasnon,Ines Nakouri,Laure Césaire,Michel Depontville,Catherine Nganoa,Diane Kottler,

Nicolas Aide^*

This version is not peer-reviewed.

Altmetrics

Downloads

151

Views

247

Comments

Submitted:

21 January 2021

Posted:

25 January 2021

You are already at the latest version

Abstract

Keywords:

Subject:

Medicine and Pharmacology - Immunology and Allergy

Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.

Alerts

MDPI Initiatives

Important Links

Choose an area of interest and we will send you notifications of new preprints at your preferred frequency.

Disclaimer